Literature DB >> 26239417

HLA-B polymorphisms and intracellular assembly modes.

Malini Raghavan1, Jie Geng2.   

Abstract

Human leukocyte antigen (HLA) class I molecules are ligands for antigen receptors of cytotoxic T cells (CTL) and inhibitory receptors of natural killer (NK) cells. The high degree of HLA class I polymorphism allows for the selection of distinct and diverse sets of antigenic peptide ligands for presentation to CTL. The extensive polymorphisms of the HLA class I genes also result in large variations in their intracellular folding and assembly characteristics. Recent findings indicate that North American HLA-B variants differ significantly in the stabilities of their peptide-deficient forms and in the requirements for the endoplasmic reticulum (ER)-resident factor tapasin for proper assembly. In HIV-infected individuals, the presence of tapasin-independent HLA-B allotypes links to more rapid progression to death. Further studies are important to better understand how the intrinsic structural characteristics of HLA class I folding intermediates affect immune responses mediated by CTL and NK cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; Calreticulin; ERp57; Endoplasmic reticulum; HIV; HLA-B; MHC class I; Peptide loading complex; TAP transporter; Tapasin

Mesh:

Substances:

Year:  2015        PMID: 26239417      PMCID: PMC4681577          DOI: 10.1016/j.molimm.2015.07.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  26 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Optimization of the MHC class I peptide cargo is dependent on tapasin.

Authors:  Anthony P Williams; Chen Au Peh; Anthony W Purcell; James McCluskey; Tim Elliott
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

Review 3.  What chickens would tell you about the evolution of antigen processing and presentation.

Authors:  Jim Kaufman
Journal:  Curr Opin Immunol       Date:  2015-01-24       Impact factor: 7.486

Review 4.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

Review 6.  Calreticulin in the immune system: ins and outs.

Authors:  Malini Raghavan; Sanjeeva J Wijeyesakere; Larry Robert Peters; Natasha Del Cid
Journal:  Trends Immunol       Date:  2012-09-07       Impact factor: 16.687

7.  HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Authors:  Rujun Song; Irene Lisovsky; Bertrand Lebouché; Jean-Pierre Routy; Julie Bruneau; Nicole F Bernard
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

8.  The IPD and IMGT/HLA database: allele variant databases.

Authors:  James Robinson; Jason A Halliwell; James D Hayhurst; Paul Flicek; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

Review 9.  Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function.

Authors:  Andy van Hateren; Alistair Bailey; Jörn M Werner; Tim Elliott
Journal:  Mol Immunol       Date:  2015-03-26       Impact factor: 4.407

Review 10.  HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion.

Authors:  David R Collins; Kathleen L Collins
Journal:  PLoS Pathog       Date:  2014-01-23       Impact factor: 6.823

View more
  13 in total

Review 1.  Strategies for the measurements of expression levels and half-lives of HLA class I allotypes.

Authors:  Malini Raghavan; Brogan Yarzabek; Anita J Zaitouna; Sujatha Krishnakumar; Daniel S Ramon
Journal:  Hum Immunol       Date:  2019-02-05       Impact factor: 2.850

2.  Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.

Authors:  Brogan Yarzabek; Anita J Zaitouna; Eli Olson; Gayathri N Silva; Jie Geng; Aviva Geretz; Rasmi Thomas; Sujatha Krishnakumar; Daniel S Ramon; Malini Raghavan
Journal:  Elife       Date:  2018-07-10       Impact factor: 8.140

3.  HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.

Authors:  E Ashouri; P J Norman; L A Guethlein; A S Han; N Nemat-Gorgani; S J Norberg; A Ghaderi; P Parham
Journal:  HLA       Date:  2016-08-24       Impact factor: 4.513

4.  Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.

Authors:  Zhi-Jie Han; Wei-Wei Xue; Lin Tao; Feng Zhu
Journal:  CNS Neurosci Ther       Date:  2018-08-14       Impact factor: 5.243

Review 5.  A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Authors:  Devin Dersh; Jaroslav Hollý; Jonathan W Yewdell
Journal:  Nat Rev Immunol       Date:  2020-08-20       Impact factor: 53.106

6.  Chickens as a simple system for scientific discovery: The example of the MHC.

Authors:  Clive A Tregaskes; Jim Kaufman
Journal:  Mol Immunol       Date:  2021-04-09       Impact factor: 4.407

Review 7.  From Chickens to Humans: The Importance of Peptide Repertoires for MHC Class I Alleles.

Authors:  Jim Kaufman
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

8.  HLA-B and cysteinylated ligands distinguish the antigen presentation landscape of extracellular vesicles.

Authors:  Julia Bauzá-Martinez; Albert J R Heck; Wei Wu
Journal:  Commun Biol       Date:  2021-07-01

9.  Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes.

Authors:  Nathalia Beatriz Ramos de Sá; Marcelo Ribeiro-Alves; Tatiana Pereira da Silva; Jose Henrique Pilotto; Valeria Cavalcanti Rolla; Carmem B W Giacoia-Gripp; Daniel Scott-Algara; Mariza Gonçalves Morgado; Sylvia Lopes Maia Teixeira
Journal:  BMC Infect Dis       Date:  2020-01-20       Impact factor: 3.090

Review 10.  Variations in MHC class I antigen presentation and immunopeptidome selection pathways.

Authors:  Anita J Zaitoua; Amanpreet Kaur; Malini Raghavan
Journal:  F1000Res       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.